We are live on ! Find out more
ProShare Advisors

ProShare Advisors Portfolio holdings

AUM $67.5B
1-Year Est. Return 28.09%
This Fund
S&P 500
This Quarter Est. Return
-4.19%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$26.1B
AUM Growth
-$4.09B
Cap. Flow
-$2.77B
Cap. Flow %
-10.63%
Top 10 Hldgs %
22.95%
Holding
1,846
New
56
Increased
388
Reduced
1,301
Closed
96

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$366M
2
MSFT icon
Microsoft
MSFT
+$279M
3
AMZN icon
Amazon
AMZN
+$213M
4
TSLA icon
Tesla
TSLA
+$109M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$104M

Sector Composition

Rank Sector Weight
1 Technology 23.74%
2 Consumer Staples 11.79%
3 Consumer Discretionary 11.57%
4 Industrials 10.74%
5 Healthcare 10.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EGHT icon
1651
8x8 Inc
EGHT
$247M
$57K ﹤0.01%
16,439
+690
+4% +$3.3K
QSI icon
1652
Quantum-Si Incorporated
QSI
$168M
$56K ﹤0.01%
20,113
+582
+3% +$1.86K
ARLO icon
1653
Arlo Technologies
ARLO
$1.4B
$55K ﹤0.01%
11,957
-89
-0.7% -$558
CCO icon
1654
Clear Channel Outdoor Holdings
CCO
$1.23B
$55K ﹤0.01%
40,657
-359
-0.9% -$543
YEXT icon
1655
Yext
YEXT
$501M
$55K ﹤0.01%
12,554
-945
-7% -$4.38K
GBIO
1656
DELISTED
Generation Bio
GBIO
$54K ﹤0.01%
+1,025
New +$64.1K
PBI icon
1657
Pitney Bowes
PBI
$2.42B
$54K ﹤0.01%
23,490
-638
-3% -$2.05K
BHIL
1658
DELISTED
Benson Hill, Inc.
BHIL
$52K ﹤0.01%
539
-11
-2% -$1.21K
PSFE icon
1659
Paysafe
PSFE
$407M
$51K ﹤0.01%
3,107
-59
-2% -$1.32K
ACCO icon
1660
Acco Brands
ACCO
$369M
$50K ﹤0.01%
10,143
-491
-5% -$3.11K
GEVO icon
1661
Gevo
GEVO
$397M
$50K ﹤0.01%
21,699
-413
-2% -$1.15K
TTI icon
1662
TETRA Technologies
TTI
$1.23B
$50K ﹤0.01%
13,722
-262
-2% -$1.03K
HRTX icon
1663
Heron Therapeutics
HRTX
$86.3M
$48K ﹤0.01%
11,344
-218
-2% -$853
WKHS icon
1664
Workhorse Group
WKHS
$29.5M
$48K ﹤0.01%
6
+1
+20% +$9.72K
SLGC
1665
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
$48K ﹤0.01%
16,496
-316
-2% -$1.33K
ABUS icon
1666
Arbutus Biopharma
ABUS
$865M
$47K ﹤0.01%
24,515
+802
+3% +$1.89K
ATAI icon
1667
AtaiBeckley Inc
ATAI
$2.66B
$45K ﹤0.01%
13,611
+1,094
+9% +$4.49K
BLND icon
1668
Blend Labs
BLND
$409M
$45K ﹤0.01%
20,394
-390
-2% -$1.11K
PDYN icon
1669
Palladyne AI
PDYN
$233M
$44K ﹤0.01%
3,268
+721
+28% +$13.5K
CNSL
1670
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
$44K ﹤0.01%
10,599
-256
-2% -$1.58K
ABSI icon
1671
Absci
ABSI
$1.28B
$42K ﹤0.01%
+13,617
New +$50K
DOUG icon
1672
Douglas Elliman
DOUG
$155M
$42K ﹤0.01%
10,677
-320
-3% -$1.58K
HYLN icon
1673
Hyliion Holdings
HYLN
$663M
$42K ﹤0.01%
14,629
-280
-2% -$1.02K
OCGN icon
1674
Ocugen
OCGN
$410M
$42K ﹤0.01%
23,594
-451
-2% -$1.12K
EGIO
1675
DELISTED
Edgio, Inc. Common Stock
EGIO
$42K ﹤0.01%
378
-8
-2% -$947

Similar funds

ProShare Advisors's Q3 2022 Portfolio in Review

As of Q3 2022, ProShare Advisors held 1,846 positions worth $26.1B, down 14% from $30.2B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

ProShare Advisors withdrew a net $2.77B in Q3 2022, closing 96 positions and reducing 1,301 holdings. Its most notable exit was Neenah, Inc. Common Stock, an estimated $7.52M position sold in full.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 26% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.

Against the trend, ProShare Advisors opened a new position in Xometry worth $7.31M.

  • ProShare Advisors's largest Q3 2022 buy was Xometry: 128,758 shares worth $7.31M.
  • ProShare Advisors added most to Target in Q3 2022, an estimated $49.4M increase.
  • ProShare Advisors's biggest Q3 2022 reduction was Apple, cutting an estimated $366M.
  • ProShare Advisors fully exited Neenah, Inc. Common Stock in Q3 2022, selling an estimated $7.52M.
  • ProShare Advisors's ten largest holdings make up 23% of its $26.1B portfolio in Q3 2022.
  • ProShare Advisors opened 56 new positions and closed 96 in Q3 2022.
  • ProShare Advisors's portfolio value fell 14% quarter-over-quarter to $26.1B.

Based on ProShare Advisors's 13F filing for Q3 2022, filed 7 Nov 2022.